No clinically significant cardiac arrhythmias, stroke or myocardial infarction within  months prior to enrollment
Myocardial infarction within the past  months
Acute myocardial infarction </= months prior to enrollment
Myocardial infarction within  months prior to study entry,
Myocardial infarction within the last  months
Acute myocardial infarction ? months prior to Day 
Myocardial infarction within the previous  months before planned first dose of study drug
Myocardial infarction within  months of study dose
Subjects with myocardial infarction (heart attack) within  year
No uncontrolled arrhythmia; no myocardial infarction in the last  months
Myocardial infarction within  months prior to initiation of screening
Other serious intercurrent chronic or acute illness, including myocardial infarction or cerebrovascular event within  months
Myocardial infarction and/or new ST elevation
Ischemic cardiac event including myocardial infarction within  months prior to first dose
Myocardial infarction,
Myocardial infarction in the previous  weeks (from the start of treatment)
Significant cardiac disease such as recent myocardial infarction
Myocardial infarction within the  months prior to study drug administration
History of a recent myocardial infarction (within one year), a past myocardial infarction (more than one year ago) along with current coronary symptoms requiring medications
Ischemic cardiac event including myocardial infarction within  months prior to first dose;
Myocardial infarction within  months of starting study drug
Myocardial infarction within  months
No stroke, myocardial infarction, or major surgery within  months of starting on therapy
History of an ischemic cardiac event including myocardial infarction within  months of study entry
Myocardial infarction within  months of study entry
No uncontrolled arrhythmia; no myocardial infarction in the last  months
Myocardial infarction within  months of study entry
Myocardial infarction less than  months before study enrollment
Myocardial infarction or cardiac surgery within  months prior to enrollment
myocardial infarction in the previous six months
Myocardial infarction
Subjects that have had a myocardial infarction within the last  months
Prior myocardial infarction within one year of study entry
Myocardial infarction <  months prior to screening
Documented myocardial infarction within six months of enrollment.
Significant cardiac disease such as recent myocardial infarction
Myocardial infarction within  months prior to study entry
Unstable cardiac disease despite treatment, myocardial infarction within  months prior to study entry
Patients with documented myocardial infarction within six months of protocol entry
Recent (within twelve months) myocardial infarction.
Myocardial infarction within  months of study initiation
Acute myocardial infarction =<  months prior to starting drug
Myocardial infarction
Myocardial infarction
myocardial infarction within  months prior to randomization;
No myocardial infarction <  months
Myocardial infarction
Myocardial infarction
Documented myocardial infarction or unstable/uncontrolled cardiac disease within  months of randomization
Myocardial infarction within the last  months
Patients who have had a myocardial infarction, intracranial bleed, or stroke within the past  months are not eligible
Subjects with active cardiovascular disease not medically controlled or those who have had myocardial infarction in the past  months..
Myocardial infarction within  months before the Day  visit.
Myocardial infarction within  months before CD.
Documented myocardial infarction < months from study entry
Acute myocardial infarction
Myocardial infarction
Patients within three months of a myocardial infarction
Myocardial infarction in the previous  weeks (from the start of treatment)
Myocardial infarction in the previous  weeks (from the start of treatment)
Myocardial infarction within the past  months before the first dose of study drug
History or clinical signs of myocardial infarction within  year prior to study entry
Myocardial infarction within  months prior to starting study
Myocardial infarction within four months prior to enrollment
Myocardial infarction within  months of treatment
Acute myocardial infarction ? months prior to study participation
Myocardial infarction within  months prior to starting treatment
Echocardiogram should be done within  days of starting therapy if there are cardiac risk factors (e.g., history of hypertension or of myocardial infarction)
Myocardial infarction in the previous  weeks (from the start of treatment)
Documented myocardial infarction or unstable/uncontrolled cardiac disease within  months of enrollment
Myocardial infarction ?  months prior to enrolment.
Myocardial infarction < months from study entry
Myocardial infarction within  months prior to screening;
Acute myocardial infarction ?  months prior to starting study drug
Myocardial infarction within  months of Screening visit;
Subject has had an acute myocardial infarction (AMI)
Myocardial infarction within one year prior to study entry.
Cardiomyopathy or a myocardial infarction within the past  months.
A myocardial infarction within  months prior to study entry;
Patients with documented myocardial infarction within six months of protocol entry
Myocardial infarction  months prior to screening
Acute myocardial infarction within  months before starting study drug.
Unstable cardiac disease or myocardial infarction within  months prior to study entry
Recent myocardial infarction
History of an ischemic cardiac event including myocardial infarction within  months of study entry
Unstable cardiac disease or myocardial infarction within  months prior to study entry
myocardial infarction (within the last  months)
Medically eligible to use nicotine replacement therapy (patient currently hospitalized with acute myocardial infarction/ST elevation myocardial infarction [STEMI], unstable angina, uncontrolled arrhythmia, stroke, peripheral arterial disease vascular surgery will not be eligible for inclusion)
Myocardial infarction
Recent myocardial infarction
Acute myocardial infarction within  days
Myocardial infarction within  months prior to CD.
History or clinical signs of myocardial infarction within  year of study entry
Acute myocardial infarction within  months before starting study drug.
Myocardial infarction within the last  months
Myocardial infarction within the last  months